<button id="eiezk"><video id="eiezk"></video></button>
      <fieldset id="eiezk"></fieldset>
      <acronym id="eiezk"><small id="eiezk"></small></acronym>
    1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
      <acronym id="eiezk"><address id="eiezk"></address></acronym>
        <source id="eiezk"><pre id="eiezk"></pre></source>

        產(chǎn)品名稱(chēng) SHP099
        產(chǎn)品貨號(hào) Axon 2633 CAS [1801747-42-1] MF C16H19Cl2N5MW 352.26 Purity: 99% Soluble in DMSO Description Highly potent, selective and orally bioavailable SHP2 inhibitor (IC50 value 0.071 μM) that stabilizes SHP2 in an auto-inhibited conformation. SHP099 potently inhibits ERK phosphorylation and the growth of cancer cell lines that have alterations in RTKs or other tyrosine kinases such as the Janus kinases JAK1 and JAK2. SHP099 showed no detectable activity against a panel of 21 phosphatases and 66 kinases (including the closest homologue SHP1), and only had modest activity against 5HT3 when profiled against a preclinical safety pharmacology panel representing 49 common adverse drug reaction targets. KEYWORDS:?SHP099 | supplier | SHP2 inhibitor | SHP-099 | SHP 099 | CAS [1801747-42-1] | [1801747-11-4] | Tyrosine Phosphatase | PTP | PTPN11 | PTP-2C | programmed cell death pathway | PD-1/PD-L1 | Noonan | Leopard | RAS-ERK signaling
        產(chǎn)品價(jià)格 現(xiàn)貨詢(xún)價(jià),電話:010-67529703
        產(chǎn)品規(guī)格
        產(chǎn)品品牌 axonmedchem
        產(chǎn)品概述
        產(chǎn)品詳情

        SHP099

        Based on 2 reference(s) in Google Scholar 10 10 2

        Axon 2633

        CAS [1801747-42-1]

        MF C16H19Cl2N5
        MW 352.26

        • Purity: 99%
        • Soluble in DMSO

        SHP099

        Description

        Highly potent, selective and orally bioavailable SHP2 inhibitor (IC50 value 0.071 μM) that stabilizes SHP2 in an auto-inhibited conformation. SHP099 potently inhibits ERK phosphorylation and the growth of cancer cell lines that have alterations in RTKs or other tyrosine kinases such as the Janus kinases JAK1 and JAK2. SHP099 showed no detectable activity against a panel of 21 phosphatases and 66 kinases (including the closest homologue SHP1), and only had modest activity against 5HT3 when profiled against a preclinical safety pharmacology panel representing 49 common adverse drug reaction targets.

        KEYWORDS:?SHP099 | supplier | SHP2 inhibitor | SHP-099 | SHP 099 | CAS [1801747-42-1] | [1801747-11-4] | Tyrosine Phosphatase | PTP | PTPN11 | PTP-2C | programmed cell death pathway | PD-1/PD-L1 | Noonan | Leopard | RAS-ERK signaling

        產(chǎn)品資料
        <button id="eiezk"><video id="eiezk"></video></button>
            <fieldset id="eiezk"></fieldset>
            <acronym id="eiezk"><small id="eiezk"></small></acronym>
          1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
            <acronym id="eiezk"><address id="eiezk"></address></acronym>
              <source id="eiezk"><pre id="eiezk"></pre></source>

              黄片av免费在线,久久精品国产亚洲a∨蜜臀,福利视频网站 | 粉嫩AV无码一区二区三区软件,瑶脱了内裤打开腿让人摸,国产性爱在线视频不卡 | 蜜桃操逼视频,男的操女的逼,黄片入口 | 爱逼爱操,人奶人xxxxhd奶水,久久骚逼 | 蜜桃黄色视频,国产女人18毛片水真多,成人三级一区 | 中文字幕视频2023,久久久久亚洲精品中文字幕,亚洲无码成人网 | www.嫩草,我要看特级片,国产综合中文字幕 | 国产精品久久毛片A片,中文字幕黄色大片,麻豆天堂在线观看了 | 国产极品久久,不知火舞被爆操,波多野结衣国产区42部 | 成人国产精品秘 在线观看,国产精品亚洲区,黄射网站 |